Cargando…
Epidemiology of Chronic Effects of Traumatic Brain Injury
Although many patients diagnosed with traumatic brain injury (TBI), particularly mild TBI, recover from their symptoms within a few weeks, a small but meaningful subset experience symptoms that persist for months or years after injury and significantly impact quality of life for the person and their...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122127/ https://www.ncbi.nlm.nih.gov/pubmed/33947273 http://dx.doi.org/10.1089/neu.2021.0062 |
_version_ | 1784711278119354368 |
---|---|
author | Haarbauer-Krupa, Juliet Pugh, Mary Jo Prager, Eric M Harmon, Nicole Wolfe, Jessica Yaffe, Kristine |
author_facet | Haarbauer-Krupa, Juliet Pugh, Mary Jo Prager, Eric M Harmon, Nicole Wolfe, Jessica Yaffe, Kristine |
author_sort | Haarbauer-Krupa, Juliet |
collection | PubMed |
description | Although many patients diagnosed with traumatic brain injury (TBI), particularly mild TBI, recover from their symptoms within a few weeks, a small but meaningful subset experience symptoms that persist for months or years after injury and significantly impact quality of life for the person and their family. Factors associated with an increased likelihood of negative TBI outcomes include not only characteristics of the injury and injury mechanism, but also the person’s age, pre-injury status, comorbid conditions, environment, and propensity for resilience. In this article, as part of the Brain Trauma Blueprint: TBI State of the Science framework, we examine the epidemiology of long-term outcomes of TBI, including incidence, prevalence, and risk factors. We identify the need for increased longitudinal, global, standardized, and validated assessments on incidence, recovery, and treatments, as well as standardized assessments of the influence of genetics, race, ethnicity, sex, and environment on TBI outcomes. By identifying how epidemiological factors contribute to TBI outcomes in different groups of persons and potentially impact differential disease progression, we can guide investigators and clinicians toward more-precise patient diagnosis, along with tailored management, and improve clinical trial designs, data evaluation, and patient selection criteria. |
format | Online Article Text |
id | pubmed-9122127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-91221272022-05-20 Epidemiology of Chronic Effects of Traumatic Brain Injury Haarbauer-Krupa, Juliet Pugh, Mary Jo Prager, Eric M Harmon, Nicole Wolfe, Jessica Yaffe, Kristine J Neurotrauma Article Although many patients diagnosed with traumatic brain injury (TBI), particularly mild TBI, recover from their symptoms within a few weeks, a small but meaningful subset experience symptoms that persist for months or years after injury and significantly impact quality of life for the person and their family. Factors associated with an increased likelihood of negative TBI outcomes include not only characteristics of the injury and injury mechanism, but also the person’s age, pre-injury status, comorbid conditions, environment, and propensity for resilience. In this article, as part of the Brain Trauma Blueprint: TBI State of the Science framework, we examine the epidemiology of long-term outcomes of TBI, including incidence, prevalence, and risk factors. We identify the need for increased longitudinal, global, standardized, and validated assessments on incidence, recovery, and treatments, as well as standardized assessments of the influence of genetics, race, ethnicity, sex, and environment on TBI outcomes. By identifying how epidemiological factors contribute to TBI outcomes in different groups of persons and potentially impact differential disease progression, we can guide investigators and clinicians toward more-precise patient diagnosis, along with tailored management, and improve clinical trial designs, data evaluation, and patient selection criteria. 2021-12 2021-08-17 /pmc/articles/PMC9122127/ /pubmed/33947273 http://dx.doi.org/10.1089/neu.2021.0062 Text en https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Article Haarbauer-Krupa, Juliet Pugh, Mary Jo Prager, Eric M Harmon, Nicole Wolfe, Jessica Yaffe, Kristine Epidemiology of Chronic Effects of Traumatic Brain Injury |
title | Epidemiology of Chronic Effects of Traumatic Brain Injury |
title_full | Epidemiology of Chronic Effects of Traumatic Brain Injury |
title_fullStr | Epidemiology of Chronic Effects of Traumatic Brain Injury |
title_full_unstemmed | Epidemiology of Chronic Effects of Traumatic Brain Injury |
title_short | Epidemiology of Chronic Effects of Traumatic Brain Injury |
title_sort | epidemiology of chronic effects of traumatic brain injury |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122127/ https://www.ncbi.nlm.nih.gov/pubmed/33947273 http://dx.doi.org/10.1089/neu.2021.0062 |
work_keys_str_mv | AT haarbauerkrupajuliet epidemiologyofchroniceffectsoftraumaticbraininjury AT pughmaryjo epidemiologyofchroniceffectsoftraumaticbraininjury AT pragerericm epidemiologyofchroniceffectsoftraumaticbraininjury AT harmonnicole epidemiologyofchroniceffectsoftraumaticbraininjury AT wolfejessica epidemiologyofchroniceffectsoftraumaticbraininjury AT yaffekristine epidemiologyofchroniceffectsoftraumaticbraininjury |